Preview

Российский неврологический журнал

Расширенный поиск
Доступ открыт Открытый доступ  Доступ закрыт Только для подписчиков

Кардиоцеребральный синдром при хронической сердечной недостаточности

https://doi.org/10.30629/2658-7947-2022-27-1-26-30

Полный текст:

Аннотация

В статье обсуждаются патогенез и проявления кардиоцеребрального синдрома у пациентов с сердечной недостаточностью (СН). СН является одной из значимых проблем пожилого возраста ввиду высокой распространенности. Рассматриваются механизмы влияния СН на развитие острой и хронической ишемии головного мозга, часто сопровождающейся когнитивными и эмоционально-аффективными расстройствами. Для оптимального комплексного подхода к ведению пациентов с кардиоцеребральным синдромом целесообразно участие кардиологов, неврологов и психиатров.

Об авторах

К. А. Ерусланова
ФГАОУ ВО РНИМУ им. Н.И. Пирогова Минздрава России, Российский геронтологический научно-клинический центр
Россия

Москва



Э. А. Мхитарян
ФГАОУ ВО РНИМУ им. Н.И. Пирогова Минздрава России, Российский геронтологический научно-клинический центр
Россия

Мхитарян Элен Араиковна

Москва



А. Д. Изюмов
ФГАОУ ВО РНИМУ им. Н.И. Пирогова Минздрава России, Российский геронтологический научно-клинический центр
Россия

Москва



А. Б. Сейфетдинова
ФГАОУ ВО РНИМУ им. Н.И. Пирогова Минздрава России, Российский геронтологический научно-клинический центр
Россия

Москва



Ю. В. Котовская
ФГАОУ ВО РНИМУ им. Н.И. Пирогова Минздрава России, Российский геронтологический научно-клинический центр
Россия

Москва



О. Н. Ткачёва
ФГАОУ ВО РНИМУ им. Н.И. Пирогова Минздрава России, Российский геронтологический научно-клинический центр
Россия

Москва



Список литературы

1. Squire I. Socioeconomic status and outcomes in heart failure with reduced ejection fraction. Heart. 2018;104(12):966–967. https://doi.org/10.1136/heartjnl-2017-312814 Epub 2018 Jan 25. PMID: 29371375

2. Фомин И.В. Хроническая сердечная недостаточность в Российской Федерации: что сегодня мы знаем и что должны делать. Российский кардиологический журнал. 2016;8:7–13. https://doi.org/10.15829/1560-4071-2016-8-7-13

3. Britt H.C., Harrison C.M., Miller G.C., Knox S.A. Prevalence and patterns of multimorbidity in Australia. Med. J. Aust. 2008;189:72–77.

4. Doehner W., Ural D., Haeusler K.G., Čelutkienė J., Bestetti R., Cavusoglu Y. et al. Heart and brain interaction in patients with heart failure: overview and proposal for a taxonomy. A position paper from the Study Group on Heart and Brain Interaction of the Heart Failure Association. Eur. J. Heart Fail. 2018;20(2):199–215. https://doi.org/10.1002/ejhf.1100 Epub 2017 Dec 27. PMID: 29280256

5. Kannel W.B., Wolf P.A., Verter J. Manifestations of coronary disease predisposing to stroke. The Framingham study. JAMA. 1983;250(21):2942–2946.

6. Adelborg K., Szépligeti S., Sundbøll J., Horváth-Puhó E., Henderson V.W., Ording A. et al. Risk of Stroke in Patients With Heart Failure: A Population-Based 30-Year Cohort Study. Stroke. 2017;48(5):1161–1168. https://doi.org/10.1161/STROKEAHA.116.016022 Epub 2017 Apr 4. PMID: 28377383

7. Sandhu R.K., Hohnloser S.H., Pfeffer M.A., Yuan F., Hart R.G., Yusuf S. et al. Relationship between degree of left ventricular dysfunction, symptom status, and risk of embolic events in patients with atrial fibrillation and heart failure. Stroke. 2015;46. https://doi.org/10.1161/StrokeAHA.114.007140

8. Abdul-Rahim A.H., Perez A.C., MacIsaac R.L., Jhund P.S., Claggett B.L., Carson P.E. et al. Candesartan in Heart failure Assessment of Reduction in Mortality and Morbidity-Preserved (CHARM-Preserved) and the Irbesartan in Heart Failure with Preserved Systolic Function (I-Preserve) Steering Committees. Risk of stroke in chronic heart failure patients with preserved ejection fraction, but without atrial fibrillation: analysis of the CHARM-Preserved and I-Preserve trials. Eur. Heart J. 2017;38(10):742–750. https://doi.org/10.1093/eurheartj/ehw509 Erratum in: Eur. Heart J. 2018;39(16):1403. PMID: 28426886; PMCID: PMC5460584

9. Chung Seyong, Kim Tae-Hoon, Uhm Jae-Sun, Cha Myung-Jin, Lee JungMyung, Park Junbeom et al. Stroke and Systemic Embolism and other Adverse Outcomes of Heart Failure with Preserved and Reduced Ejection Fraction in Patients with Atrial Fibrillation (From the Cоmparison study of Drugs for symptom control and complication prеvention of Atrial Fibrillation [CODE-AF]). The American Journal of Cardiology. 2019. S000291491931104X. https://doi.org/10.1016/j.amjcard.2019.09.035

10. Thomas I., EncisoSilva J., Schlueter M., Greenberg B. Anticoagulation Therapy and NOACs in Heart Failure. Handb. Exp. Pharmacol. 2017;243:515–535. https://doi.org/10.1007/164_2016_126

11. Cuadrado-Godia E., Ois A., Roquer J. Heart failure in acute ischemic stroke. Curr. Cardiol. Rev. 2010;6(3):202–213. https://doi.org/10.2174/157340310791658776

12. Kumar R., Yadav S.K., Palomares J.A., Park B., Joshi S.H., Ogren J.A. et al. Reduced regional brain cortical thickness in patients with heart failure. PLoS One. 2015;10(5):e0126595. https://doi.org/10.1371/journal.pone.0126595. PMID: 25962164; PMCID: PMC4427362

13. Mueller K., Thiel F., Beutner F., Teren A., Frisch S., Ballarini T. et al. Brain Damage With Heart Failure: Cardiac Biomarker Alterations and Gray Matter Decline. Circ. Res. 2020;126(6):750–764. https://doi.org/10.1161/CIRCRESAHA.119.315813 Epub 2020 Jan 23. PMID: 31969053; PMCID: PMC7077969

14. Saglietto A., Scarsoglio S., Canova D., Roatta S., Gianotto N., Piccotti A. et al. Increased beat-to-beat variability of cerebral microcirculatory perfusion during atrial fibrillation: a near-infrared spectroscopy study. Europace. 2021;23(8):1219–1226. https://doi.org/10.1093/europace/euab070. PMID: 33846732

15. Gardarsdottir M., Sigurdsson S., Aspelund T., Gardarsdottir V.A., Forsberg L., Gudnason V., Arnar D.O. Improved brain perfusion after electrical cardioversion of atrial fibrillation. Europace. 2020;22(4):530–537. https://doi.org/10.1093/europace/euz336 PMID: 31860069; PMCID: PMC7132536

16. Gardarsdottir M., Sigurdsson S., Aspelund T., Rokita H., Launer L..J, Gudnason V., Arnar D.O. Atrial fibrillation is associated with decreased total cerebral blood flow and brain perfusion. Europace. 2018;20(8):1252–1258. doi: 10.1093/europace/eux220 PMID: 29016776; PMCID: PMC6075509

17. McDonagh T.A., Metra M., Adamo M., Gardner R.S., Baumbach A., Böhm M. et al.; ESC Scientific Document Group. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur. Heart J. 2021;42(36):3599–3726. https://doi.org/10.1093/eurheartj/ehab368 Erratum in: Eur. Heart J. 2021;Oct 14: PMID: 34447992

18. Hindricks G., Potpara T., Dagres N., Arbelo E., Bax J.J., Blomström-Lundqvist C. et al.; ESC Scientific Document Group. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur. Heart J. 2021;42(5):373–498. https://doi.org/10.1093/eurheartj/ehaa612 Erratum in: Eur. Heart J. 2021;42(5):507. Erratum in: Eur. Heart J. 2021;42(5):546–547. Erratum in: Eur. Heart J. 2021;42(40):4194. PMID: 32860505

19. Ampadu J., Morley J.E. Heart failure and cognitive dysfunction. Int. J. Cardiol. 2015;178:12–23. https://doi.org/10.1016/j.ijcard.2014.10.087

20. Hajduk A.M., Lemon S.C., McManus D.D., Lessard D.M., Gurwitz J.H., Spencer F.A. et al. Cognitive impairment and self‐care in heart failure. Clin. Epidemiol. 2013;5:407–416.

21. Zuccalà G., Pedone C., Cesari M., Onder G., Pahor M., Marzetti E. et al. The effects of cognitive impairment on mortality among hospitalized patients with heart failure. Am. J. Med. 2003;115(2):97–103. https://doi.org/10.1016/s0002-9343(03)00264-x PMID: 12893394

22. Cermakova P., Lund L.H., Fereshtehnejad S.M., Johnell K., Winblad B., Dahlström U., Religa D. Heart failure and dementia: survival in relation to types of heart failure and different dementia disorders. Eur. J. Heart Fail. 2015;17:612–619.

23. Alwerdt J., Edwards J.D., Athilingam P., O’Connor M.L., Valdes E.G. Longitudinal differences in cognitive functioning among older adults with and without heart failure. J. Aging. Health. 2013;25:1358–1377.

24. Alagiakrishnan K., Mah D., Ahmed A., Ezekowitz J. Cognitive decline in heart failure. Heart Fail Rev. 2016;21:661–673.

25. Pan A., Kumar R., Macey P.M., Fonarow G.C., Harper R.M., Woo M.A. Visual assessment of brain magnetic resonance imaging detects injury to cognitive regulatory sites in patients with heart failure. J. Card. Fail. 2013;19:94–100.

26. Woo M.A., Ogren J.A., Abouzeid C.M., Macey P.M., Sairafian K.G., Saharan P.S. et al. Regional hippocampal damage in heart failure. Eur. J. Heart Fail. 2015;17:494–500.

27. van den Hurk K., Reijmer Y.D., van den Berg E., Alssema M., Nijpels G., Kostense P.J. et al. Heart failure and cognitive function in the general population: the Hoorn Study. Eur. J. Heart Fail. 2011;13:1362–1369.

28. Čelutkienė J., Vaitkevičius A., Jakštienė S., Jatužis D. Expert opinion— cognitive decline in heart failure: more attention is needed. Card. Fail Rev. 2016;2:106–109.

29. Jefferson A.L., Tate D.F., Poppas A., Brickman A.M., Paul R.H., Gunstad J., Cohen R.A. Lower cardiac output is associated with greater white matter hyperintensities in older adults with cardiovascular disease. J. Am. Geriatr. Soc. 2007;55(7):1044–8. https://doi.org/10.1111/j.1532-5415.2007.01226.x PMID: 17608877; PMCID: PMC2721459

30. Alosco M.L., Brickman A.M., Spitznagel M.B., Garcia S.L., Narkhede A., Griffith E.Y. et al. Cerebral perfusion is associated with white matter hyperintensities in older adults with heart failure. Congest. Heart Fail. 2013 Jul-Aug;19(4):E29-34. https://doi.org/10.1111/chf.12025. Epub 2013 Mar 20. PMID: 23517434; PMCID: PMC3692594

31. Kumar R., Yadav S.K., Palomares J.A., Park B., Joshi S.H., Ogren J.A. et al. Reduced regional brain cortical thickness in patients with heart failure. PLoS One. 2015;10:e0126595.

32. Kumar R., Woo M.A., Macey P.M., Fonarow G.C., Hamilton M.A., Harper R.M. Brain axonal and myelin evaluation in heart failure. J. Neurol. Sci. 2011;307:106–113.

33. Saglietto A., Scarsoglio S., Canova D., Roatta S., Gianotto N., Piccotti A. et al. Increased beat-to-beat variability of cerebral microcirculatory perfusion during atrial fibrillation: a near-infrared spectroscopy study. EP Europace. 2021;euab070. https://doi.org/10.1093/europace/euab070

34. Harjola V.P., Mullens W., Banaszewski M., Bauersachs J., Brunner-La Rocca H.P., Chioncel O. et al. Organ dysfunction, injury and failure in acute heart failure: from pathophysiology to diagnosis and management. A review on behalf of the Acute Heart Failure Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). Eur. J. Heart Fail. 2017;19(7):821–836. https://doi.org/10.1002/ejhf.872 Epub 2017 May 30. PMID: 28560717; PMCID: PMC5734941

35. Kindermann I., Fischer D., Karbach J., Link A., Walenta K., Barth C. et al. Cognitive function in patients with decompensated heart failure: the Cognitive Impairment in Heart Failure (CogImpair-HF) study. Eur. J. Heart Fail. 2012;14(4):404–13. https://doi.org/10.1093/eurjhf/hfs015 PMID: 22431406

36. Ponikowski P., Voors A.A., Anker S.D., Bueno H., Cleland J.G., Coats A.J. et al. Authors/Task Force Members; Document Reviewers. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur. J. Heart Fail. 2016;18(8):891–975. https://doi.org/10.1002/ejhf.592 Epub 2016 May 20. PMID: 27207191

37. Rutledge T., Reis V.A., Linke S.E., Greenberg B.H., Mills P.J. Depression in heart failure a meta-analytic review of prevalence, intervention effects, and associations with clinical outcomes. J. Am. Coll. Cardiol. 2006;48(8):1527–37. https://doi.org/10.1016/j.jacc.2006.06.055 Epub 2006 Sep 26. PMID: 17045884

38. Lane D.A., Chong A.Y., Lip G.Y. Psychological interventions for depression in heart failure. Cochrane Database Syst. Rev. 2005;(1):CD003329. Published 2005 Jan 25. https://doi.org/10.1002/14651858.CD003329.pub2

39. Jeyanantham K., Kotecha D., Thanki D., Dekker R., Lane D.A. Effects of cognitive behavioural therapy for depression in heart failure patients: a systematic review and meta-analysis. Heart Fail Rev. 2017;22(6):731–741. https://doi.org/10.1007/s10741-017-9640-5

40. Kim J.M., Stewart R., Lee Y.S., Lee H.J., Kim M.C., Kim J.W. et al. Effect of escitalopram vs placebo treatment for depression on long‐term cardiac outcomes in patients with acute coronary syndrome: a randomized clinical trial. JAMA. 2018;350–358.

41. Zambrano J., Celano C.M., Januzzi J.L., Massey C.N., Chung W.J., Millstein R.A., Huffman J.C. Psychiatric and Psychological Interventions for Depression in Patients With Heart Disease: A Scoping Review. J. Am. Heart Assoc. 2020;9(22):e018686. https://doi.org/10.1161/JAHA.120.018686 Epub 2020 Nov 7. PMID: 33164638; PMCID: PMC7763728

42. Sokoreli I., de Vries J.J., Pauws S.C., Steyerberg E.W. Depression and anxiety as predictors of mortality among heart failure patients: systematic review and meta‐analysis. Heart Fail Rev. 2016;21:49–63.

43. Celik E., Cay S., Sensoy B., Murat S., Oksuz F., Cankurt T., Ali Mendi M. Heart Failure Functional Class Associated with Depression Severity But Not Anxiety Severity. Acta Cardiol. Sin. 2016;32(1):55–61. https://doi.org/10.6515/acs20150509a PMID: 27122931; PMCID: PMC4804941

44. Aggelopoulou Z., Fotos N.V., Chatziefstratiou A.A., Giakoumidakis K., Elefsiniotis I., Brokalaki H. The level of anxiety, depression and quality of life among patients with heart failure in Greece. Appl. Nurs. Res. 2017;34:52–56.

45. Tsuchihashi‐Makaya M., Matsuo H., Kakinoki S., Takechi S., Kinugawa S., Tsutsui H. J‐HOMECARE Investigators. Home‐based disease management program to improve psychological status in patients with heart failure in Japan. Circ. J. 2013;77:926–933.

46. Рачин А.П., Аверченкова А.А. Идебенон (Нобен) — от теории к практике. Журн. неврологии и психиатрии им. С.С. Корсакова. 2011;111(5):81–84.

47. Боголепова А.Н., Коваленко Е.А. Терапия астенических и когнитивных нарушений при хронической ишемии головного мозга: возможности идебенона. Неврология Психиатрия. 2016;4(121):4–7.

48. Обрезан А.Г., Куликов Н.В. Нейрогуморальный дисбаланс при хронической сердечной недостаточности: классические и современные позиции. Российский кардиологический журнал. 2017;(9):83–92.https://doi.org/10.15829/1560-4071-2017-9-83-92

49. Floras J.S. Sympathetic nervous system activation in human heart failure: clinical implications of an updated model. J. Am. Coll. Cardiol. 2009;54:375–385.

50. Abboud H., Berroir S., Labreuche J., Orjuela K., Amarenco P. GENIC Investigators. Insular involvement in brain infarction increases risk for cardiac arrhythmia and death. Ann. Neurol. 2006;59(4):691–9. https://doi.org/10.1002/ana.20806 PMID: 16566012

51. Cowie M.R., Woehrle H., Wegscheider K., Angermann C., d’Ortho M.P., Erdmann E. et al. Adaptive Servo-Ventilation for Central Sleep Apnea in Systolic Heart Failure. N. Engl. J. Med. 2015;373(12):1095–105. https://doi.org/10.1056/NEJMoa1506459 Epub 2015 Sep 1. PMID: 26323938; PMCID: PMC4779593

52. van Bilsen M., Patel H.C., Bauersachs J., Böhm M., Borggrefe M., Brutsaert D. et al. The autonomic nervous system as a therapeutic target in heart failure: a scientific position statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology. Eur. J. Heart Fail. 2017;19:1361–1378.


Рецензия

Для цитирования:


Ерусланова К.А., Мхитарян Э.А., Изюмов А.Д., Сейфетдинова А.Б., Котовская Ю.В., Ткачёва О.Н. Кардиоцеребральный синдром при хронической сердечной недостаточности. Российский неврологический журнал. 2022;27(1):26-30. https://doi.org/10.30629/2658-7947-2022-27-1-26-30

For citation:


Eruslanova K.A., Mkhitaryan E.A., Izyumov A.D., Seifetdinova A.B., Kotovskaya Yu.V., Tkachyova O.N. Cardio-cerebral syndrome in patients with chronic heart failure. Russian neurological journal. 2022;27(1):26-30. (In Russ.) https://doi.org/10.30629/2658-7947-2022-27-1-26-30

Просмотров: 153


ISSN 2658-7947 (Print)
ISSN 2686-7192 (Online)